Juneko E Grilley-Olson

Juneko E Grilley-Olson

UNVERIFIED PROFILE

Are you Juneko E Grilley-Olson?   Register this Author

Register author
Juneko E Grilley-Olson

Juneko E Grilley-Olson

Publications by authors named "Juneko E Grilley-Olson"

Are you Juneko E Grilley-Olson?   Register this Author

22Publications

502Reads

28Profile Views

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.

Lancet Oncol 2019 Sep 24;20(9):1295-1305. Epub 2019 Jul 24.

Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30405-XDOI Listing
September 2019

Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.

Int J Radiat Oncol Biol Phys 2019 03 2;103(3):646-653. Epub 2018 Nov 2.

Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; UNC Lineberger Comprehensive Cancer Center, University of North Carolina Hospitals, Chapel Hill, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183392
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.10.033DOI Listing
March 2019

Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

Arch Pathol Lab Med 2018 12 30;142(12):1537-1548. Epub 2018 Apr 30.

From the Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill (Drs Funkhouser Jr and Banks); Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina (Drs Funkhouser Jr, Hayes, Nikolaishvilli-Feinberg, and Grilley-Olson; Messrs Moore and Jo; and Ms Eeva); the Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina (Drs Hayes and Grilley-Olson); the Department of Computer Sciences, University of Wisconsin, Madison (Mr Funkhouser III); the Department of Biostatistics, UNC School of Public Health, Chapel Hill, North Carolina (Dr Fine); Medical Affairs, Ventana Medical Systems, Tucson, Arizona (Dr Banks); Unit of Pathology, Scientific Institute for Research and Health Care, San Giovanni Rotondo, Italy (Dr Graziano); the Department of Pathology, VA Medical Center, Durham, North Carolina (Dr Boswell); the Department of Medical Biosciences, Pathology, Umeå University Hospital, Umeå, Sweden (Dr Elmberger); the Department of Pathology, Kaiser-Permanente Hospital, Santa Clara, California (Dr Raparia); the Department of Pathology, Piedmont Medical Center, Rock Hill, South Carolina (Dr Hart); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); the Department of Pathology, Suburban Hospital, Bethesda, Maryland (Dr Nolan); the Department of Pathology, Mayo Clinic, Rochester, Minnesota (Dr Fritchie); the Department of Pathology, VA Medical Center, Dayton, Ohio (Dr Pouagare); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Rex Hospital, Raleigh, North Carolina (Dr Volmar); the Department of Pathology, Medical College of Georgia, Augusta (Drs Biddinger and Kleven); the Department of Pathology, Flagstaff Medical Center, Flagstaff, Arizona (Dr Papez); the Department of Pathology, VA Medical Center, Charleston, South Carolina (Dr Spencer); the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Mino-Kenudson and Hariri); and the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Driver and Cagle). Dr Allen is currently located at the Department of Pathology at University of Mississippi Medical Center, Jackson.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0481-OADOI Listing
December 2018

Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.

Cancer 2018 07 9;124(14):2986-2992. Epub 2018 May 9.

Division of Head and Neck Surgery, Department of Otolaryngology, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31526DOI Listing
July 2018

Multidisciplinary Management of Oligometastatic Soft Tissue Sarcoma.

Am Soc Clin Oncol Educ Book 2018 May;38:939-948

From the Department of Medicine, Division of Hematology-Oncology, UNC Lineberger Cancer Center, The University of North Carolina, Chapel Hill, NC; Orthopaedic Oncology at Aurora Cancer Care, Orthopaedic Surgery, Aurora St. Luke's Medical Center, Milwaukee, WI; Department of Cardiothoracic Surgery, Aurora Healthcare, Milwaukee, WI; Department of Radiology, Duke University Medical Center, Durham, NC; Department of Radiation Oncology, Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200573DOI Listing
May 2018

Can we predict the response to therapy in soft tissue sarcoma?

Future Oncol 2018 01 8;14(2):101-104. Epub 2017 Dec 8.

Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0497DOI Listing
January 2018

Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.

JAMA Otolaryngol Head Neck Surg 2016 06;142(6):517-23

Department of Radiation Oncology, University of North Carolina, Chapel Hill4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2016.0656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928525PMC
June 2016

Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma.

Lung Cancer 2014 Nov 30;86(2):255-61. Epub 2014 Aug 30.

The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, United States; Department of Internal Medicine, Division of Hematology/Oncology, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362696PMC
November 2014

If histology matters...

J Clin Oncol 2010 Apr 8;28(11):1810-2. Epub 2010 Mar 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.1247DOI Listing
April 2010